Coronavirus (COVID-19) Update: September 10, 2021 | FDA – FDA.gov

For Immediate Release: September 10, 2021

The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:

The FDA recognizes the increased demand for certain products during the COVID-19 public health emergency and has prioritized the review of generic drug applications for potential treatments and supportive therapies for patients with COVID-19. We remain deeply committed to facilitating access to safe and effective medical products to help address critical needs of the American public.

The FDA issued this guidance so that the development of generic drugs and submission of applications can continue during the COVID-19 public health emergency, ultimately helping ensure Americans continue to have access to safe and effective generic drugs.

###

Boilerplate

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nations food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

09/10/2021

View post:

Coronavirus (COVID-19) Update: September 10, 2021 | FDA - FDA.gov